CALCA and bone metastasis: Similarly, for patients with bone metastasis, the median calcitonin and CEA level decreased significantly in the anlotinib arm, from 14306 ng/L to 7798 ng/L (P < 0.0001), 129 ng/mL to 101 ng/mL (P= 0.003), respectively.